+44 (0)20 3910 4640 hello@symmetron.net

ISPOR Europe 2019

2-6 November 2019; Copenhagen, Denmark

Monday, 4 November

Assessing the quality and coherence of network meta-analyses of biologics in plaque psoriasis - what does all this evidence synthesis tell us?

Wright E, Yasmeen N, Malottki K, Sawyer L, Borg E, Schwenke C, Warren R

Network meta-analysis comparing palbociclib plus fulvestrant with everolimus plus exemestane for HR+/HER2- advanced breast cancer that has become resistant to previous endocrine therapy

LeReun C, Gentilini A, Large S, Chowdhury M, Smith TA, Rinciog C

Tuesday, 5 November

Determining the baseline strategy in a cost-effectiveness analysis with treatment sequences

Giulia Viola M, Diamantopoulos A, Sawyer L

Wednesday, 6 November

Colectomy for ulcerative colitis in the United Kingdom: A review of incidence and complications

Diamantopoulos A, Lohan C, Sawyer L

An economic evaluation of tofacitinib in the treatment of moderately to severely active ulcerative colitis in the United Kingdom

Diamantopoulos A, Lohan C, Le Reun C, Wright E, Bohm N, Sawyer L

A systematic review and network meta-analysis to evaluate the efficacy and safety of tofacitinib in the treatment of moderately to severely active ulcerative colitis

Le Reun C, Wright E, Lohan C, Diamantopoulos A, Bohm N, Sawyer L